跳至主要内容
临床试验/PACTR202104622127025
PACTR202104622127025尚未招募未知

Placenta Plasmodium Parasitaemia and Development of Resistance using Sulfadoxine/Pyrimethamine (SP) or Mefluoquine IPT/ITN Intervention among HIV Positive Pregnant Women in Lagos Nigeria: A Randomised Controlled Trial

igerian Institute of Medical Research0 个研究点目标入组 200 人开始时间: 2021年4月6日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • A. HIV POSITIVE POPULATION
  • 1.HIV positive pregnant women
  • 2. Above 13wks gestational age
  • 3. Afebrile at the time of recruitment
  • 4.Not sensitive to sulphadozine
  • 5. Not sensitive to standard ITN
  • 6.Not sensitive to mefloquine
  • B. HIV NEGATIVE POPULATION
  • 1.HIV negative pregnant women
  • 2. Above 13wks gestational age
  • 3. Afebrile at the time of recruitment
  • 4.Not sensitive to sulphadozine
  • 5. Not sensitive to mefloquine
  • 6. Not sensitive to standard ITN

排除标准

  • A. HIV POSITIVE POPULATION
  • 1. SCD IN PREGNANCY
  • 2. Known febrile illness in the Index pregnancy
  • 3. Known sensitivity to sulphadozine/pyrimethamine combination
  • 4. Known sensitive to mefloquine
  • B. HIV NEGATIVE POPULATION
  • 1. SCD IN PREGNANCY
  • 2. Known febrile illness in the Index pregnancy
  • 3. Known sensitivity to sulphadozine/pyrimethamine
  • 4. Known sensitivity to mefloquine

研究者

发起方
igerian Institute of Medical Research

相似试验